Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1

American Journal of Veterinary Research

Volumn 59, Issue 10, 1998, Pages 1317-1322

  Boury, Nancy Maroushek ^a   Bosworth, Brad T ^b   Stabel, Thomas J ^b   Kehrli Jr , Marcus E ^b   Taylor, Michael J ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL; ANIMAL DISEASE; ANIMAL SALMONELLOSIS; ARTICLE; BIOSYNTHESIS; DOSE RESPONSE; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; SOLUBILITY; SWINE; SWINE DISEASE;

ANIMALS; ANTIGENS, CD; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; SALMONELLA INFECTIONS, ANIMAL; SOLUBILITY; SWINE; SWINE DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032177720     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-452.
2. Tracey K, Cerami A. Tumor necrosis factor: an updated review of its biology. Crit Care Med 1993;21:S415-S422.
3. Tracey K, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapuetic target. Annu Rev Med 1994;45:491-503.
4. Tite J, Dougan G, Chatfield S. The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol 1991;147:3161-3164.
5. Nauciel C, Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun 1992;60:450-454.
6. Arnold J, Niesel D, Annable C, et al. Tumor necrosis factor-alpha mediates the early pathology in Salmonella infection of the gastrointestinal tract. Microb Pathog 1993;14:217-227.
7. Jotwani R, Tanaka Y, Watanabe K, et al. Cytokine stimulation during Salmonella typhimurium sepsis in Itys mice. J Med Microbiol 1995;42:348-352.
8. Mastroeni P, Skepper J, Hormaeche C. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect Immun 1995;63:3674-3682.
9. Mastroeni P, Villarreal-Ramos B, Hormaeche C. Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model. Microb Pathog 1993;14:473-480.
10. Eckmann L, Fierer J, Kagnoff M. Genetically resistant (Ityr) and susceptible (Itys) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J Immunol 1996;156:2894-2900.
11. Rothe J, Gehr G, Loetscher H, et al. Tumor necrosis factor receptors-structure and function. Immunol Res 1992;11:81-90.
12. Tartaglia L, Weber R, Figari I, et al. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A 1991;88:9292-9296.
13. Dembic Z, Loetscher H, Gubler U, et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990;2:231-237.
14. Bjornberg F, Lantz M, Olsson I, et al. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms. Lymphokine Cytokine Res 1994;13:203-211.
15. Van Zee K, Kohno T, Fischer E, et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845-4849.
16. Lesslauer W, Tabuchi H, Gentz R, et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 1991;21:2883-2886.
17. Aderka D, Engelmann H, Hornik V. Increased serum receptors for tumor necrosis factor in cancer patients. Cancer Res 1991;51:5602-5607.
18. Aukrust P, Liabackk N, Muller F, et al. Serum levels of tumor necrosis factor (TNF) and soluble TNF receptors in human immunodeficiency virus type I infection. Correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994;169:420-424.
19. Keuter M, Dharmana E, Gasem M, et al. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994;169:1306-1311.
20. Butler T, Ho M, Acharya G, et al. Interleukin 6, gamma interferon and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob Agents Chemother 1993;37:2418-2421.
21. Diez-Ruiz A, Tilz G, Zangerle R, et al. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
22. Hale KK, Smith CG, Baker SL, et al. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine 1995;7:26-38.
23. Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:1548-1561.
24. Stabel TJ, Fedorka-Cray PJ, Gray JT. Tumor necrosis factor-production in swine after oral or respiratory challenge exposure with live Salmonella typhimurium or Salmonella choleraemis. AmJ Vet Res 1995;56:1012-1018.
25. Isreal D. A PCR-based method for high stringency screening of DNA libraries. Nucleic Acids Res 1993;21:2627-2631.
26. Gray P, Barrett K, Chantry D, et al. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci U S A 1990;87: 1380-1384.
27. Lewis M, Tartaglia L, Lee A, et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A 1991;88:2830-2834.
28. Benton W, Davis R. Screening λ gt recombinant clones by hybridization to single plaques in situ. Science 1977;196:180-182.
29. Malik A, McLEan P, Roberts A, et al. A simple high yield method for the preparation of gt10 DNA suitable for subcloning, amplification and sequencing. Nucleic Acids Res 1990;18:4031-4032.
30. Lee L, Connell C, Woo S, et al. DNA sequencing with dye-labeled terminators and T7 DNA polymerase: effect of dyes and dNTPs on incorporation of dye-terminators and probability analysis of termination fragments. Nucleic Acids Res 1992;20:2471-2483.
31. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;277:680-685.
32. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
33. Hitcock P, Brown T. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver stained polyacrylamide gels. J Bacteriol 1983;154:269-277.
34. Bertoni G, Kuhnert P, Peterhans E, et al. Improved bioassay for the detection of porcine tumor necrosis factor using a homologous cell line: PK(15). J Immunol Methods 1993;160:267-271.
35. Suter B, Pauli U. Cloning of the cDNA encoding the porcine p55 tumor necrosis factor receptor. Gene 1995;163:263-266.
36. SAS. User's guide: statistics. 6th ed. Cary, NC: SAS Institute Inc. 1989.
37. Himmler A, Mauer-Fogy I, Kronke M, et al. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble dirivate, tumor necrosis factor binding protein. DNA Cell Biol 1990;9:705-715.
38. Gulberg U, Lantz M, Lindvall L, et al. Involvement of an Asn/Val cleavage site in the production of a soluble form of a human tumor necrosis factor (TNF) receptor. Site directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain. Eur J Cell Biol 1992;58:307-312.
39. Brakebusch C, Varfolomeev E, Batkin M, et al. Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. J Biol Chem 1994;269:32488-32496.
40. Ehlers M, Riordan J. Membrane proteins with soluble coun-terparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 1991;30:10065-10074.
41. Merli S, Corti A, Cassani G. Production of soluble tumor necrosis factor receptor type I in Escherichia coli: optimization of the refolding yields by a microtiter dilution assay. Anal Biochem 1995;230:85-91.
42. Strandberg L, Enfors S. Factors influencing inclusion body formation in the production of a fused protein in Escherichia coli. Appl Environ Microbiol 1991;57:1669-1674.
43. Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995;269:1270-1272.
44. LeClair KP, Blanar MA, Sharp PA. The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc Natl Acad Sci U S A 1992;89:8145-8149.
45. Saccardo MB, Grazioli L, Cozzi E, et al. Expression, in Escherichia coli, of a soluble human tumor necrosis factor receptor. J Biotechnol 1993;30:367-378.
46. Heilig B, Fiehn C, Brockhaus M, et al. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematosus, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993;13:321-328.